Antiepileptogenesis after stroke—trials and tribulations: Methodological challenges and recruitment results of a Phase II study with eslicarbazepine acetate

Antiepileptogenesis after stroke—trials and tribulations: Methodological challenges and recruitment results of a Phase II study with eslicarbazepine acetate

Abstract There is currently no evidence to support the use of antiseizure medications to prevent unprovoked seizures following stroke. Experimental animal models suggested a potential antiepileptogenic effect for eslicarbazepine acetate (ESL), and a Phase II, multicenter, randomized, double‐blind, p...

Full description

Bibliographic Details
Main Authors: Matthias J. Koepp, Eugen Trinka, Yee‐Haur Mah, Carla Bentes, Susanne Knake, Gian Luigi Gigli, José M. Serratosa, Johan Zelano, Luís M. Magalhães, Ana Pereira, Joana Moreira, Patrício Soares‐da‐Silva
Format: Article
Language:English
Published: Wiley 2023-09-01
Series:Epilepsia Open
Subjects:
acute intracerebral hemorrhage or infarct
antiseizure medication
epilepsy
epileptogenesis
unprovoked seizure
Online Access:https://doi.org/10.1002/epi4.12735

Similar Items

Similar Items